Trial intelligence / Profile preview

Gabapentin and TAP Blocks for Postoperative Pain

NCT02927405Phase 4Withdrawn

Sponsor
SUNY Downstate Health Sciences University
Start
Mar 2020
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing TAP Block plus placebo with TAP Block plus gabapentin (2 arms). Primary endpoint: Post-operative morphine consumption at 24 hours. Planned start Mar 2020; status: withdrawn.

02

Drugs

gabapentin
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02927405.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02927405.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call